Randox Laboratories Ltd is proud to announce that in April 2011 we signed a multi-year agreement with the Premier Healthcare Alliance for the supply of Acusera Quality Control (QC) materials. The agreement will provide the 90,000 plus Premier members with access to our extensive range of quality control products and the benefits they offer clinical laboratories. When asked about the new agreement Laura Coyle Randox Business Manager for the USA revealed that ‘We look forward to strengthening our relationship with Premier and providing added value to their members’.
The Acusera range of quality controls is extensive covering over 300 routine and esoteric parameters. Our multi-analyte QC allows laboratories to simplify their quality control practices by dramatically reducing the number of controls used, the consolidation of QC gives the added benefit of cost and time savings. All analytes are present at clinically relevant levels further eliminating the need to purchase additional and often expensive low/high level controls.
With 30 years experience in quality control manufacture; excellent choice, stability and most importantly performance is guaranteed. All controls are manufactured to the highest specifications at our FDA inspected facilities in the United Kingdom, this commitment to quality is emphasised by ISO 13485 accreditation for the development and manufacture of diagnostic test kits.
As a true supplier of third party controls Randox products provide an unbiased, independent assessment of performance. Our unique value assignment process employs over 16,000 laboratories worldwide making our controls the most accurately assigned on the market. To maintain the high quality expected from Randox we add no preservatives or stabilisers to our control products which can often lead to interference problems, inconvenience and expense for the laboratory. In addition to this many of our controls are made from 100% human serum providing a matrix similar to the patient sample and eliminating possible interference with antibody based tests.
Many of our controls have a shelf life of up to four years from the date of manufacture; this not only allows for long term QC monitoring but can significantly reduce costs and the problems associated with changing lot numbers.
Our comprehensive control options include both liquid ready-to-use and lyophilised controls and cover everything from routine chemistries, immunoassays, immunology/proteins, tumour markers, toxicology, cardiology, lipids, urinalysis, coagulation, therapeutic drugs, blood gas and maternal screening to more specialised controls like antioxidants, cytokines and growth factors.
Visit our stand (#1301) at the 2011 AACC / ASCLS Annual Meeting in Atlanta, Georgia, from 24th - 28th July to learn more about our range of quality management solutions and find out how we can help you save money by consolidating control usage in your laboratory.
Headquartered in the United Kingdom, Randox Laboratories Ltd. is a market leader within the in vitro diagnostics industry, manufacturing high quality diagnostic products for laboratories worldwide. Our extensive product portfolio offers complete solutions within the fields of clinical chemistry, cardiology, forensic toxicology, veterinary, drug residues, life sciences, oncology, molecular diagnostics and internal and external quality control. Our goal is to ‘revolutionise healthcare through continuously improving diagnostic solutions.’ We continue to achieve this year after year due to our commitment and significant re-investment in Research and Development. Our innovative approach to diagnostics allows us to develop revolutionary products, specifically designed to provide more efficient, higher quality and reliable results, ensuring patients receive the right diagnosis at the right time. For more information contact us at [email protected]
About the Premier Healthcare Alliance
Premier is a performance improvement alliance of more than 2,500 U.S. hospitals and 75,000-plus other healthcare sites using the power of collaboration to lead the transformation to high quality, cost-effective care. Owned by hospitals, health systems and other providers, Premier maintains the nation's most comprehensive repository of clinical, financial and outcomes information and operates a leading healthcare purchasing network. A world leader in helping deliver measurable improvements in care, Premier has worked with the Centers for Medicare & Medicaid Services and the United Kingdom's National Health Service North West to improve hospital performance. Headquartered in Charlotte, N.C., Premier also has an office in Washington. http://www.premierinc.com.